{
  "id": 7849207,
  "title": "Walker & Dunlop stock hits 52-week low at 38.96 USD",
  "url": "https://urgent.news/2026/09/16/walker-dunlop-stock-hits-52-week-low-at-38-96-usd",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-16T18:55:48.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/company-news/walker--dunlop-stock-hits-52week-low-at-3896-usd-93CH-4904321"
  },
  "original_language": "en",
  "account": "Walker & Dunlop Inc. stock has plummeted to a 52-week low of 38.96 USD, marking a 53.97% decline over the past year. The company's stock price has plummeted significantly, reflecting both market-wide challenges and specific issues affecting the business. In the second quarter of 2026, Walker & Dunlop reported mixed financial results. While the company exceeded analyst expectations with adjusted core diluted earnings of $1.19 per share, revenue fell short by $30.83 million, falling to $306.7 million against an estimated $337.53 million. Despite these mixed results, Citizens, a major financial institution, has lowered its price target for Walker & Dunlop shares from $70 to $55, retaining a \"Market Outperform\" rating. The downgrade reflects concerns, including ongoing fraud-related issues, which led to a revised price target of 11.8 times the revised 2027 earnings per share. This represents a reduction from the previous 14.0 times multiple, indicating a more cautious outlook on the company's future performance.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Medical Properties Trust stock hits 52-week low at 3.5 USD",
        "url": "https://urgent.news/2026/09/16/medical-properties-trust-stock-hits-52-week-low-at-3-5-usd",
        "published": "2026-09-16T16:41:41.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}